BIO-CAT (Troy, VA) has announced that it is joining the Lallemand (Canada) family. Effective July 31, 2026, Lallemand Inc. has completed its acquisition of BIO-CAT Enzymes & Microbials.
Together, BIO-CAT and Lallemand said that they are combining complementary expertise in enzymes, microbial technologies, fermentation and life science innovation to create an even stronger platform for developing next-generation solutions for the human health, animal nutrition, agriculture, food and industrial markets.
“When my father, Ed Schuler, and I founded BIO-CAT in 1988, we built the company around family values, science, integrity and lasting relationships,” said Chris Schuler. “Finding a partner with shared values was just as important as finding one with complementary technologies. Lallemand’s family-owned heritage, long-term vision, and commitment to its people and customers made this a natural fit, and we’re excited about what we’ll accomplish together.”
“The acquisition will reinforce our presence in the dietary food supplement and health ingredient markets, and increase our production footprint and capacity in the USA,” added Antoine Chagnon, CEO of Lallemand. “This, in turn, should better enable us to meet the requirements of our existing and new customers across the global animal nutrition, agriculture and food industries.”
For more information, visit www.bio-cat.com or www.lallemand.com/en/.
